There’s always a lot of criticism around the approach taken by modern medicine toward cancer. It makes perfect sense that any for profit company will only fund research that is likely to result in profits for them, in the long run. Unfortunately, this goal is directly in opposition to the goal of quickly and permanently eliminating the disease from a person. This is true for all kinds of diseases, especially chronic conditions.
However, it’s not always the case that there is no research towards cures. The Atlantic details successes in immunotherapy that may be a cure for some cancer patients. And of course the Kanzius treatment is in its final set of animal trials before going to the FDA to get approval for human trials. Yay!